MORE►
National Institutes of Health
Dr. Ruben Amarasingham, founder and CEO of Pieces
Dallas’ Pieces Technologies Gets $2M from National Cancer Institute to Advance Conversational AI for Cancer Patients
by Lance Murray | Oct 30, 2024
With the NCI funding—which follows Piece's $25 million growth financing round announced in September—Pieces will partner with Cleveland-based MetroHealth to deploy a new conversational AI agent for cancer patients called "PiecesChat."
by Quincy Preston |
Feb 6, 2024
Neal Smatresk's decade at UNT sparked big changes and growth, boosting its standing in academics and research. From "record-breaking enrollment" to "making UNT the highest-ranked Tier One institution in the North Texas region," his tenure marks transformation across multiple fronts.
MORE►
by Lance Murray |
Jun 22, 2023
"There are over 10,000 rare diseases that affect millions of people worldwide, and most of them are genetic," notes UT Southwestern's Steven Gray (above, with Susan Iannaccone, M.D.). Testing on a total of eight genetic diseases has been approved for funding by the Bespoke Gene Therapy Consortium and other organizations.
MORE►
by David Seeley |
Apr 20, 2023
According to the NIH, up to 5% of people worldwide have improperly aligned eyesight—a condition known as strabismus. An even higher percentage of people suffer from computer vision syndrome—digital eye strain caused by prolonged use of digital devices. Today Neurolens announced a milestone in alleviating the conditions' symptoms, seven months after raising $67 million to fund the company's growth.
MORE►
[Image: Myvector/iStockphoto]
Dallas’ MedCognetics Gets $750K NIH Grant to Research Unbiased AI for Breast Cancer Detection
by David Seeley | Jan 26, 2023
Last month, we told you about MedCognetics getting FDA clearance for its unbiased AI-enabled software for breast cancer screening. Today, the Dallas-based company announced it has been awarded $750,000 from an NIH program to research unbiased AI for breast cancer detection.
The NIH's AIM-AHEAD program—short for Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity—awarded the grant. "This NIH grant will play an important role in future product development as well as helping us further expand our global market penetration," said MedCognetics CEO Debasish Nag.
MORE►
by Lance Murray |
Dec 21, 2022
UT Southwestern researchers have used gene editing technology to develop what could be a breakthrough for dilated cardiomyopathy, a heart condition that affects one in 250 people worldwide.
“The pace of this field is really breathtaking,” said Eric Olson, Ph.D., who co-led the study. “I expect that if this moves forward into patients, we’re not talking within decades—we’re talking within years.”
MORE►
by Lance Murray |
Nov 9, 2022
The Perot family’s support will expand the number of students admitted to UT Southwestern's dual-degree program as well as research disciplines in which they study, to include biomedical engineering, computational biology, bioinformatics, and data science.
The funding will enhance the curriculum and experiences of Medical Scientist Training Program students and increase efforts to recruit students from elite U.S. colleges, including top international students who want to stay in the U.S. for their careers.
MORE►
by Kevin Cummings |
Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE►
Sid O’Bryant, professor and executive director of the HSC Institute for Translational Research. [Photo: HSC]
‘We Are Going to Change the World’: $150M Grant Fuels UNT Health Science Center’s Diversity-Focused Alzheimer’s Research
by Kevin Cummings | Oct 3, 2022
The funding from the National Institutes of Health will help UNT HSC at Fort Worth advance its ongoing research on how Alzheimer's disease affects different racial and ethnic groups. Sid O'Bryant, executive director of UNT HSC's Institute for Translational Research, said there's never been a large-scale study like this before.
“This award and project are nothing short of a bio behavioral ‘moonshot’ program," adds Brian Gladue, HSC executive VP for research and innovation.
MORE►
by Kevin Cummings |
Aug 9, 2022
“Opioids are diabolical, because they actually change the structure and function of your brain; they change the way your reward system works,” said Daniel Powell, CEO at Spark Biomedical.
Meet Powell and six other startup leaders.
Meet Powell and six other startup leaders.
MORE►
by Kevin Cummings |
Jul 25, 2022
Plus, Fort Worth's Harvest Returns raises new fund; new Ryan acquisition makes 2022 its most active M&A year; OpTic Gaming acquires Dallas chatbot startup; Dallas legal education firm boosts digital content library; and Fort Worth's Novaria Group acquires firm with giant aerospace clients.
MORE►
by Kevin Cummings |
Jul 20, 2022
UT Dallas-based Qualia Oto is developing the next generation of cochlear implants, and has announced closing a Series A preferred round of around $1.64 million.
Unlike typical cochlear implants that use bundles of wires attached to a receiver to stimulate the auditory nerve, Qualia Oto’s implant uses thin-film electrode arrays embedded in a polymer, allowing for more contact with the inner ear. That translates to a higher quality and range of sounds that are able to be transmitted.
MORE►
View to North Korea Propaganda village or Peace Village at the Korean Demilitarized Zone. [Image: Loes Kieboom/istockphoto]
Discovery: UNTHSC Expands Pain Research Registry, UT Arlington Student Gets NIH Pre-Doctoral Fellowship
by Lance Murray | May 17, 2019
Also, you'll find out why a researcher at the University of North Texas believes tourism and destination development could help reunite the Korean Peninsula in this roundup of research and development activity in North Texas.
MORE►
by Dave Moore |
Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber.
MORE►
by Lance Murray |
Oct 23, 2017
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems.
MORE►
by Lance Murray |
Aug 10, 2017
The institutions were evaluated based on the number of published research articles cited as major sources of third-party patent applications.
MORE►
